Combined inhibition of PD-1/PD-L1, Lag-3, and Tim-3 axes augments antitumor immunity in gastric cancer–T cell coculture models

BACKGROUND: Immunotherapy targeting PD-1 provides a limited survival benefit in patients with unresectable advanced or recurrent gastric cancer (GC). Beside PD-L1, the expression of inhibitory ligands such as CEACAM-1 and LSECtin on GC cells account for this limitation. Here we assessed their expres...

Descripción completa

Detalles Bibliográficos
Autores principales: Mimura, Kosaku, Kua, Ley-Fang, Xiao, Jin-Fen, Asuncion, Bernadette Reyna, Nakayama, Yuko, Syn, Nicholas, Fazreen, Zul, Soong, Richie, Kono, Koji, Yong, Wei-Peng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Singapore 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065004/
https://www.ncbi.nlm.nih.gov/pubmed/33611641
http://dx.doi.org/10.1007/s10120-020-01151-8

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8065004/
https://www.ncbi.nlm.nih.gov/pubmed/33611641
http://dx.doi.org/10.1007/s10120-020-01151-8

Ejemplares similares